诺舒治疗心脏病术后异常子宫出血15例报告

发布时间：2018-04-16 10:16

  本文选题：诺舒阻抗控制子宫内膜切除系统 + 异常子宫出血　； 参考：《中国微创外科杂志》2015年01期

【摘要】：目的探讨诺舒(Nova Sure)阻抗控制子宫内膜切除系统治疗心脏病术后异常子宫出血(abnormal uterine bleeding,AUB)的临床疗效。方法 2011年6月~2013年1月采用诺舒对15例心脏病术后AUB行子宫内膜去除术,术前排除子宫内膜及宫颈恶性病变,扩张宫颈后先行宫腔镜检查,然后将诺舒阻抗控制子宫内膜切除系统的双极消融器送入宫腔,测试通过后行子宫内膜去除,再次宫腔镜检查,了解子宫内膜去除情况。记录术前后情况,并进行1、3、6个月随访,观察月经情况和并发症。结果 15例术中生命体征平稳,手术顺利。血红蛋白术前(91.33±21.38)g/L,术后6个月升高至(113.89±19.32)g/L,有统计学差异(t=5.640,P=0.000),贫血状态明显好转。1例心功能由Ⅲ级变为Ⅱ级,2例心功能由Ⅱ级变为Ⅰ级,其余患者心功能未见变化。术后1、3、6个月随访15例,治疗均有效(参照月经改善评价标准),闭经率分别为66.7%(10/15)、73.3%(11/15)、80.0%(12/15)。结论诺舒阻抗子宫内膜切除术治疗心脏病术后AUB疗效确切,安全性高。
[Abstract]:Objective to investigate the clinical effect of norsuzolium Nova Sure) Impedance controlled endometrial resection system in the treatment of abnormal uterine bleeding after cardiac surgery.Methods from June 2011 to January 2013, 15 AUB patients with heart disease were treated with endometrial removal from June 2011 to January 2013. Endometrial and cervical malignant lesions were excluded before operation and hysteroscopy was performed after dilatation of cervix.Then, the bipolar ablation device controlled by Noushu impedance was put into the uterine cavity. After the test passed, the endometrium was removed and the endometrium was removed again by hysteroscopy to understand the removal of the endometrium.The data before and after operation were recorded and followed up for 3 months and 6 months to observe menstruation and complications.Results the vital signs of 15 cases were stable and the operation was smooth.Hemoglobin increased from 91.33 卤21.38 g / L to 113.89 卤19.32 g / L at 6 months postoperatively, with statistical difference of 5.640g / L. The anemia state was significantly improved from grade 鈪，

本文编号：1758454